Ethyl 5-amino-1-(pyrimidin-2-yl)-1H-pyrazole-4-carboxylate, 95.0%, 1g

N-BOC-6-hydroxy-1,4-oxazepane, 97.0%, 250mg

2-ACETYL-N,N-DIMETHYL-2,6-DIAZASPIRO[3.4]OCTANE-8-CARBOXAMIDE, 95.0%, 250mg

alpha-Galactosylceramide>95.0%(HPLC)1mg

Ethyl 3-amino-3-oxopropanoate, 98.0%, 5g

2-Chloro-6-hydroxybenzaldehyde, 95.0%, 5g

GC capillary column ROTI®Cap-XLB, 30 m, 1 Piece(s)

2,4-Dichloro-1,3,5-trifluorobenzene, 95.0%, 5g

Fuming hydrochloric acid, 37%, pa, 1 l, glass packaging

Ethyl (1S,5R,6S)-5-(pentan-3-yl-oxy)-7-oxa-bicyclo[4.1.0]hept-3-ene-3-carboxylate, 95.0%, 1g

4-(2-Chloro-thiazol-5-ylmethoxy)-piperidine-1-carboxylic acid tert-butyl ester, 100mg

1-Acetyl-4-amino-piperidine, 97.0%, 5g

Tert-butyl 2,4-dichloronicotinate, 98+%, 250mg